The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
作者信息
Beckman Joshua A, Drooz Alain T, Farber Alik, Hamdan Allen, Huber Thomas, Hussein Mohamad, Jaff Michael R, Kashyap Vikram S, McGinigle Katharine L, Menard Matthew T, Rosenfield Kenneth, Semel Marcus E, Strong Michael B, Doros Gheorghe, Creager Mark A
机构信息
Division of Vascular Medicine, University of Texas Southwestern Medical Center, Dallas (J.A.B.).
Division of Vascular and Interventional Radiology, Fairfax Radiological Consultants & INOVA Fairfax Hospital, VA (A.T.D.).
出版信息
Circulation. 2025 Aug 5;152(5):346-348. doi: 10.1161/CIRCULATIONAHA.124.072241. Epub 2025 Aug 4.
Abstract
摘要
相似文献
1
The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.冠状动脉疾病对因慢性肢体威胁性缺血而行下肢血运重建的外周动脉疾病患者的影响。
Circulation. 2025 Aug 5;152(5):346-348. doi: 10.1161/CIRCULATIONAHA.124.072241. Epub 2025 Aug 4.
2
Risk factors contributing to 30-day and 1-year mortality event scores following major lower extremity amputation for limb ischemia.肢体缺血性疾病行主要下肢截肢术后30天和1年死亡事件评分的危险因素。
J Vasc Surg. 2025 Jul;82(1):216-228.e1. doi: 10.1016/j.jvs.2025.02.030. Epub 2025 Mar 5.
3
Association of Lipoprotein(a) With Major Adverse Limb Events and All-Cause Mortality Following Revascularization for Chronic Limb-Threatening Ischemia: A Substudy of the BEST-CLI Trial.脂蛋白(a)与慢性肢体威胁性缺血血运重建术后主要不良肢体事件及全因死亡率的关联：BEST-CLI试验的一项子研究
J Am Heart Assoc. 2025 Jun 3;14(11):e041177. doi: 10.1161/JAHA.125.041177. Epub 2025 May 22.
4
The impact of postoperative dual antiplatelet therapy on outcomes of endovascular therapies in patients with chronic limb-threatening ischemia in the Vascular Quality Initiative-Medicare-linked database.血管质量倡议-医疗保险关联数据库中术后双重抗血小板治疗对慢性肢体威胁性缺血患者血管内治疗结局的影响
J Vasc Surg. 2025 Mar 18. doi: 10.1016/j.jvs.2025.03.177.
5
Prognostic value of lipoprotein(a) for cardiovascular events after lower limb revascularization in diabetic patients with chronic limb-threatening ischemia.脂蛋白(a)对慢性肢体威胁性缺血的糖尿病患者下肢血管重建术后心血管事件的预后价值。
Cardiovasc Diabetol. 2025 Jul 10;24(1):271. doi: 10.1186/s12933-025-02833-2.
6
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI.慢性肢体威胁性缺血血管重建术后的年龄相关结局：BEST-CLI分析
Circ Cardiovasc Interv. 2025 Jun;18(6):e014833. doi: 10.1161/CIRCINTERVENTIONS.124.014833. Epub 2025 Apr 3.
7
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial.BEST-CLI试验中慢性肾脏病患者慢性肢体威胁性缺血血运重建的结果
J Vasc Surg. 2025 Apr;81(4):945-956.e3. doi: 10.1016/j.jvs.2024.12.128. Epub 2025 Jan 23.
8
Impact of congestive heart failure on mid-term outcomes after lower extremity revascularization for peripheral artery disease.充血性心力衰竭对下肢外周动脉疾病血运重建术后中期结局的影响。
J Vasc Surg. 2025 May 20. doi: 10.1016/j.jvs.2025.05.027.
9
Association of Sarcopenia With Mortality in Patients With Chronic Limb-Threatening Ischemia Undergoing Endovascular Revascularization.肌肉减少症与行血管腔内重建术的慢性肢体严重缺血患者死亡率的相关性。
J Surg Res. 2023 Sep;289:52-60. doi: 10.1016/j.jss.2023.03.005. Epub 2023 Apr 19.
10
Antithrombotic treatment following revascularization for chronic limb-threatening ischaemia: a scientific statement of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.慢性肢体威胁性缺血血管重建术后的抗栓治疗：欧洲心脏病学会主动脉和外周血管疾病工作组与欧洲心脏病学会心血管药物治疗工作组的科学声明
Eur Heart J. 2025 Jul 21;46(28):2742-2759. doi: 10.1093/eurheartj/ehaf317.
本文引用的文献
1
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.低剂量利伐沙班联合阿司匹林用于接受下肢血管重建术的外周动脉疾病患者，伴或不伴有冠状动脉疾病：来自VOYAGER PAD研究的见解
Circulation. 2024 May 7;149(19):1536-1539. doi: 10.1161/CIRCULATIONAHA.124.068080. Epub 2024 May 6.
2
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血的手术或血管内治疗。
N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7.
3
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.总心血管和肢体事件以及慢性有症状外周动脉疾病中多血管疾病的影响。
J Am Heart Assoc. 2022 Jun 7;11(11):e025504. doi: 10.1161/JAHA.122.025504. Epub 2022 May 27.
4
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.替卡格雷与氯吡格雷在有症状外周动脉疾病和既往冠状动脉疾病患者中的比较：来自 EUCLID 试验的结果。
Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11.
5
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.动脉粥样硬化血栓形成门诊患者心血管危险因素的国际患病率、识别率及治疗情况
JAMA. 2006 Jan 11;295(2):180-9. doi: 10.1001/jama.295.2.180.
Zotero 插件